Development and application of a real-time on-line blinded independent central review of interim PET scans to determine treatment allocation in lymphoma trials.
about
Mantle cell lymphoma: a clinically heterogeneous disease in need of tailored approaches.The predictive role of interim positron emission tomography for Hodgkin lymphoma treatment outcome is confirmed using the interpretation criteria of the Deauville five-point scaleA functional dynamic scoring model to elucidate the significance of post-induction interim fluorine-18-fluorodeoxyglucose positron emission tomography findings in patients with Hodgkin's lymphoma.Interim FDG-PET Scan in Hodgkin's Lymphoma: Hopes and CaveatsPrognostication and Risk-Adapted Therapy of Hodgkin's Lymphoma Using Positron Emission Tomography.Survival impact of rituximab combined with ACVBP and upfront consolidation autotransplantation in high-risk diffuse large B-cell lymphoma for GELA.Positron emission tomographic scans in lymphoma: convention and controversy.Role of imaging in the staging and response assessment of lymphoma: consensus of the International Conference on Malignant Lymphomas Imaging Working Group.PET/CT adapted therapy in Hodgkin disease: current state of the art and future directions.The use of interim (18)F-fluorodeoxyglucose PET to guide therapy in lymphoma.When should FDG-PET be used in the modern management of lymphoma?WIDEN: A tool for medical image management in multicenter clinical trials.Training improves the interobserver agreement of the expert positron emission tomography review panel in primary mediastinal B-cell lymphoma: interim analysis in the ongoing International Extranodal Lymphoma Study Group-37 study.Interim positron emission tomography scan in Hodgkin lymphoma: definitions, interpretation rules, and clinical validation.Interim 18F-fluorodeoxyglucose positron emission tomography in diffuse large B-cell lymphoma: qualitative or quantitative interpretation--where do we stand?PET-guided clinical trials in Hodgkin lymphoma: to agree or not to agree, that is the reviewer's question.An international confirmatory study of the prognostic value of early PET/CT in diffuse large B-cell lymphoma: comparison between Deauville criteria and ΔSUVmax.Report on the Second International Workshop on interim positron emission tomography in lymphoma held in Menton, France, 8-9 April 2010.The Strategies to Homogenize PET/CT Metrics: The Case of Onco-Haematological Clinical Trials.
P2860
Q33586239-87E92C99-2345-4D90-9A52-396E23425F3EQ33696003-589E4F3E-4488-46BB-AB81-F83E7F73889EQ33952842-361E3258-4622-4AC5-BCB5-9424756AAF78Q34475763-6FF15A28-AF08-4184-B782-1025D0F2A95DQ34495333-83073E50-FE99-4ED9-80E5-ED1788504CBDQ35143471-96986F60-A542-4744-8199-F31D4A706806Q36399538-9FDB1F63-7550-4415-91A3-D094F9C0B96AQ37240835-73A9DEAD-BBCC-481F-A82A-46F09E88D69DQ38018865-10330E62-0B07-49A0-B02E-7947F147E6B8Q38110318-E5AF98FC-D272-481A-98B2-CB5B16726C4AQ38153086-5C9A9C86-5DC3-4487-89E4-F2BA1A10EEFFQ38202946-25AF3433-6377-4188-ADA6-C9FDEBBC2ECEQ38933091-3CAD9530-FA0F-45F4-8CA8-0E65713A5959Q43250306-ADD339E6-2C76-4D9E-9F99-4F9249A07A03Q43253516-E4C6A190-C077-4F52-8BBB-AF8DBF6424FBQ48194466-74E69D5D-AF8D-48BE-977C-63AB9D6BABE5Q51596869-069D6076-D528-455E-8F39-333A43E53D04Q53164168-544F8400-BDA2-41E2-8730-3A890E0ED966Q54152231-F3D25808-8049-47D4-AE5C-C50D75E84E3F
P2860
Development and application of a real-time on-line blinded independent central review of interim PET scans to determine treatment allocation in lymphoma trials.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh
2009年學術文章
@zh-hant
name
Development and application of ...... allocation in lymphoma trials.
@en
Development and application of ...... allocation in lymphoma trials.
@nl
type
label
Development and application of ...... allocation in lymphoma trials.
@en
Development and application of ...... allocation in lymphoma trials.
@nl
prefLabel
Development and application of ...... allocation in lymphoma trials.
@en
Development and application of ...... allocation in lymphoma trials.
@nl
P2093
P50
P356
P1476
Development and application of ...... allocation in lymphoma trials
@en
P2093
Gilles Karcher
Jean Lumbroso
John Raemaekers
Marc André
Michel Meignan
Olivier Mundler
Oumedaly Reman
Pierre Olivier
Romain Ricci
Stéphane Bardet
P304
P356
10.1200/JCO.2009.22.4089
P407
P577
2009-04-27T00:00:00Z